TUBERCULOSIS, PULMONARY
Clinical trials for TUBERCULOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 12-Week pill cocktail replace 6 months of TB treatment?
Disease control OngoingThis phase 2 trial tests whether a 12-week combination of four drugs (bedaquiline, clofazimine, pyrazinamide, and delamanid) works better than the standard 26-week treatment for drug-susceptible tuberculosis. About 94 adults with TB will be randomly assigned to either the short r…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could TB treatment be cut from 6 months to 17 weeks?
Disease control OngoingThis study tests whether two new 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 people with TB will receive one of three daily pill regimens. The goal is to see if shorter treatment can clear the infection fast…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jun 26, 2026 18:57 UTC
-
Pee test could spot TB patients skipping meds
Knowledge-focused ENROLLING_BY_INVITATIONThis study in India will test a low-cost urine check (IsoScreen) on 900 adults being treated for tuberculosis. The test detects whether they have taken their medication recently. Researchers want to see if the test can reliably find people who are missing doses, so that doctors c…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: NA • Sponsor: Tufts University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC